162 related articles for article (PubMed ID: 17590285)
21. Internet-based survey of nonmedical prescription opioid use in the United States.
Katz N; Fernandez K; Chang A; Benoit C; Butler SF
Clin J Pain; 2008; 24(6):528-35. PubMed ID: 18574362
[TBL] [Abstract][Full Text] [Related]
22. A brief survey to characterize oxycodone abuse patterns in adolescents enrolled in two substance abuse recovery high schools.
Osgood ED; Eaton TA; Trudeau JJ; Katz NP
Am J Drug Alcohol Abuse; 2012 Mar; 38(2):166-70. PubMed ID: 22220502
[TBL] [Abstract][Full Text] [Related]
23. Non-medical use and abuse of commonly prescribed medications.
Riggs P
Curr Med Res Opin; 2008 Mar; 24(3):869-77. PubMed ID: 18267053
[TBL] [Abstract][Full Text] [Related]
24. The rise of the generic drug market and its implications for dermatology.
Bhosle M; Balkrishnan R; Dewan T; Yelverton CB; Feldman SR
J Dermatolog Treat; 2005; 16(5-6):295-8. PubMed ID: 16428148
[TBL] [Abstract][Full Text] [Related]
25. Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation.
Passik SD; Hays L; Eisner N; Kirsh KL
J Pain Palliat Care Pharmacother; 2006; 20(2):5-13. PubMed ID: 16702131
[TBL] [Abstract][Full Text] [Related]
26. Trends in opioid consumption in the Nordic countries 2002-2006.
Hamunen K; Paakkari P; Kalso E
Eur J Pain; 2009 Oct; 13(9):954-62. PubMed ID: 19091608
[TBL] [Abstract][Full Text] [Related]
27. Medicaid prior authorization and controlled-release oxycodone.
Morden NE; Zerzan JT; Rue TC; Heagerty PJ; Roughead EE; Soumerai SB; Ross-Degnan D; Sullivan SD
Med Care; 2008 Jun; 46(6):573-80. PubMed ID: 18520311
[TBL] [Abstract][Full Text] [Related]
28. Abuse of prescription and over-the-counter medications.
Lessenger JE; Feinberg SD
J Am Board Fam Med; 2008; 21(1):45-54. PubMed ID: 18178702
[TBL] [Abstract][Full Text] [Related]
29. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
[TBL] [Abstract][Full Text] [Related]
30. The danger of imperfect regulation: OxyContin use in the United States and Canada.
Lexchin J; Kohler JC
Int J Risk Saf Med; 2011; 23(4):233-40. PubMed ID: 22156088
[TBL] [Abstract][Full Text] [Related]
31. Development of opioid formulations with limited diversion and abuse potential.
Fudala PJ; Johnson RE
Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S40-7. PubMed ID: 16564141
[TBL] [Abstract][Full Text] [Related]
32. The underrecognized toll of prescription opioid abuse on young children.
Bailey JE; Campagna E; Dart RC;
Ann Emerg Med; 2009 Apr; 53(4):419-24. PubMed ID: 18774623
[TBL] [Abstract][Full Text] [Related]
33. The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers.
Havens JR; Leukefeld CG; DeVeaugh-Geiss AM; Coplan P; Chilcoat HD
Drug Alcohol Depend; 2014 Jun; 139():9-17. PubMed ID: 24721614
[TBL] [Abstract][Full Text] [Related]
34. States respond to growing abuse of painkiller.
Wasserman S
State Legis; 2001; 27(9):33-4. PubMed ID: 11763873
[TBL] [Abstract][Full Text] [Related]
35. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
[TBL] [Abstract][Full Text] [Related]
36. [Me too's and generics].
Gysling E
Praxis (Bern 1994); 1999 Apr; 88(16):709-12. PubMed ID: 10355336
[TBL] [Abstract][Full Text] [Related]
37. Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.
Tsai YS; Lan SK; Ou JH; Tzai TS
Clin Ther; 2007 Apr; 29(4):670-82. PubMed ID: 17617290
[TBL] [Abstract][Full Text] [Related]
38. Drug patent expirations and the speed of generic entry.
Bae JP
Health Serv Res; 1997 Apr; 32(1):87-101. PubMed ID: 9108806
[TBL] [Abstract][Full Text] [Related]
39. Prescription Opioid Misuse Index: a brief questionnaire to assess misuse.
Knisely JS; Wunsch MJ; Cropsey KL; Campbell ED
J Subst Abuse Treat; 2008 Dec; 35(4):380-6. PubMed ID: 18657935
[TBL] [Abstract][Full Text] [Related]
40. Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment.
Butler SF; Cassidy TA; Chilcoat H; Black RA; Landau C; Budman SH; Coplan PM
J Pain; 2013 Apr; 14(4):351-8. PubMed ID: 23127293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]